REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness
NCT: NCT07792252 · NOT_YET_RECRUITING
Brief Summary
Rejoyn is a Prescription Digital Therapeutic (PDT) for adults with Major Depressive Disorder (MDD). This study aims to evaluate the feasibility, engagement, and clinical context of integrating Rejoyn into standard interventional workflows at the Yale New Haven Hospital Interventional Psychiatry Service (IPS). This is a non-significant risk, observational real-world evidence (RWE) study.
Frequently Asked Questions
What is REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness?
REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness is a clinical trial registered under NCT07792252. Current status: NOT_YET_RECRUITING.
What is the status of NCT07792252?
The current status of NCT07792252 (REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness) is: NOT_YET_RECRUITING.
When did REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness start?
REWIRE: Real-world Engagement With Interventional and Rejoyn Effectiveness started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.